Physiological modeling of age-specific changes in the pharmacokinetics of organic chemicals in children.
about
Physiologically based pharmacokinetic modeling of persistent organic pollutants for lifetime exposure assessment: a new tool in breast cancer epidemiologic studiesRelative pesticide and exposure route contribution to aggregate and cumulative dose in young farmworker childrenA physiologically based pharmacokinetic model for the assessment of infant exposure to persistent organic pollutants in epidemiologic studiesDevelopment of a physiologically based model to describe the pharmacokinetics of methylphenidate in juvenile and adult humans and nonhuman primatesThe implications of using a physiologically based pharmacokinetic (PBPK) model for pesticide risk assessmentHuman milk biomonitoring data: interpretation and risk assessment issues.Database for physiologically based pharmacokinetic (PBPK) modeling: physiological data for healthy and health-impaired elderly.The hypothalamic-pituitary-thyroid axis in infants and children: protection from radioiodinesPhysiologically based pharmacokinetic (PBPK) modeling of caffeine and theophylline in neonates and adults: implications for assessing children's risks from environmental agents.Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling: theophylline and midazolam as model drugs.Modelling approaches to dose estimation in childrenModeling the Human Kinetic Adjustment Factor for Inhaled Volatile Organic Chemicals: Whole Population Approach versus Distinct Subpopulation ApproachReview and analysis of inhalation dosimetry methods for application to children's risk assessment.Computational pharmacokinetics during developmental windows of susceptibility.Whole-body physiologically based pharmacokinetic models.Regulatory and nonregulatory strategies for improving children's environmental health in Canada.Assessing the health effects and risks associated with children's inhalation exposures--asthma and allergy.Potential new approaches for children's inhalation risk assessment.Approaches for applications of physiologically based pharmacokinetic models in risk assessment.A review of psychophysiological stressors on pharmacokinetics.Physiologically based pharmacokinetic (PBPK) modeling in children.An improved model to predict physiologically based model parameters and their inter-individual variability from anthropometry.Characterization of the human kinetic adjustment factor for the health risk assessment of environmental contaminants.Assessment of health risks resulting from early-life exposures: Are current chemical toxicity testing protocols and risk assessment methods adequate?Quantitative clinical pharmacology for size and age scaling in pediatric drug development: A systematic review.Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practice.Approaches to acrylamide physiologically based toxicokinetic modeling for exploring child-adult dosimetry differences.Physiologically based pharmacokinetic modelling of high- and low-dose etoposide: from adults to children.Derivation of cardiac output and alveolar ventilation rate based on energy expenditure measurements in healthy males and females.Age-dependent partition coefficients for a mixture of volatile organic solvents in Sprague-Dawley rats and humans.Organ growth functions in maturing male Sprague-Dawley rats based on a collective database.Organ growth functions in maturing male Sprague-Dawley rats.Development of physiologically based toxicokinetic models for improving the human indoor exposure assessment to water contaminants: trichloroethylene and trihalomethanes.Postnatal growth considerations for PBPK modeling.Assessing human variability in kinetics for exposures to multiple environmental chemicals: a physiologically based pharmacokinetic modeling case study with dichloromethane, benzene, toluene, ethylbenzene, and m-xylene.USEtox human exposure and toxicity factors for comparative assessment of toxic emissions in life cycle analysis: sensitivity to key chemical properties
P2860
Q24644907-302E2FB0-C45F-438D-8C67-AFE00941FEFAQ28382879-61564002-DCFD-4AD8-9A71-71595A690B48Q28388077-EEAC5396-44EA-4285-90EA-05C4FD43A579Q28393582-816920AA-634F-43D4-BC9A-8DF81DF37DF6Q28393965-9AE7B7B7-AE50-45DC-8B46-E46B1B450954Q31006357-743A02E8-5594-423E-A674-05DFAC2D0C04Q33396717-B341AEB5-8865-4DF6-B3F3-CA5C55675E92Q33757571-4C8980A2-816B-4FE7-BDD5-3952BA92E70CQ35624622-D08826B7-E690-42D6-9DB1-3DD436878557Q35827012-E7798F87-FE97-424C-8D3E-B9C940033F7AQ35827045-7D2E32A5-035E-49FB-8CCB-B574DD3C32E9Q35864881-1ECEF614-9EC0-4152-893B-BB5937E64B6CQ36131290-AFEFAD0E-B4A0-432E-8799-9A9CDBE38D4BQ36195215-34C3E634-5F08-40EE-976C-6F38D820B219Q36788418-5562FF91-8A5B-4456-ADA4-D67A51BAF8A3Q37030009-2CA8128C-1AB4-4F50-8C14-825B285908BEQ37039746-F5CB3564-615D-4EF7-9754-243883F24622Q37039751-26637420-8211-4F04-87AC-F35D42BC29AEQ37201545-09F94102-B05D-4D32-98CE-8BE5B599F168Q37831732-A04931E5-6E86-4FB5-94B1-3B7AFE4D13CAQ38016332-4B2CF4E5-6B44-4FC5-89F0-3BADF0C2A6F3Q38041230-41A83ED4-6424-431B-BD78-0994BC46ABE8Q38137867-F7558FBC-EA1D-4A6B-A8A1-74006B61AC84Q38357598-D8E7BC09-45B8-40E9-BED5-08D43D444778Q38502414-30439D09-0855-40A8-A96E-192BC5BE4B50Q39870288-BF9E8DCD-427F-44EB-A479-2AF673690D1EQ40148266-B997140F-2F2B-495B-B7E1-BD1081CDB0C7Q44797030-C14D7418-4E92-442E-BAC1-265CD86F49DAQ45919475-8BF2FAAE-6FC1-465F-BE59-59C639AEB36BQ46988643-5E0288BE-E90B-4201-9EA0-3F524CEDA0F3Q48170625-32E92B0B-C2BD-4B97-926F-75D08EB98B4FQ48190885-20E9CAF7-FC5B-4F63-A22E-98A70C86A973Q48650345-AB38AB1A-13F3-468E-A5EE-01B90F4622ACQ51006293-74C0CC76-ABC0-4477-B9D4-84E7F553CD9BQ53573948-6CAD0AA1-1943-4F86-B3C4-ED0201B093B7Q57238551-0B05D76F-4CB6-451C-B6C7-A88A5003AE6D
P2860
Physiological modeling of age-specific changes in the pharmacokinetics of organic chemicals in children.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Physiological modeling of age- ...... organic chemicals in children.
@ast
Physiological modeling of age- ...... organic chemicals in children.
@en
type
label
Physiological modeling of age- ...... organic chemicals in children.
@ast
Physiological modeling of age- ...... organic chemicals in children.
@en
prefLabel
Physiological modeling of age- ...... organic chemicals in children.
@ast
Physiological modeling of age- ...... organic chemicals in children.
@en
P2860
P356
P1476
Physiological modeling of age- ...... organic chemicals in children.
@en
P2093
Kannan Krishnan
Karine Price
P2860
P304
P356
10.1080/15287390306450
P50
P577
2003-03-01T00:00:00Z